Your browser doesn't support javascript.
loading
CDK4/6 signaling attenuates the effect of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer.
Hara, Naofumi; Ichihara, Eiki; Kano, Hirohisa; Ando, Chihiro; Morita, Ayako; Nishi, Tatsuya; Okawa, Sachi; Nakasuka, Takamasa; Hirabae, Atsuko; Abe, Masaya; Asada, Noboru; Ninomiya, Kiichiro; Makimoto, Go; Fujii, Masanori; Kubo, Toshio; Ohashi, Kadoaki; Hotta, Katsuyuki; Tabata, Masahiro; Maeda, Yoshinobu; Kiura, Katsuyuki.
Affiliation
  • Hara N; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Ichihara E; Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan.
  • Kano H; Department of Respiratory Medicine, Japanese Red Cross Okayama Hospital, Okayama, Japan.
  • Ando C; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Morita A; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Nishi T; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Okawa S; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Nakasuka T; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Hirabae A; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Abe M; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Asada N; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
  • Ninomiya K; Center for Comprehensive Genomic Medicine, Okayama University Hospital, Okayama, Japan.
  • Makimoto G; Center for Clinical Oncology, Okayama University Hospital, Okayama, Japan.
  • Fujii M; Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan.
  • Kubo T; Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan.
  • Ohashi K; Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan.
  • Hotta K; Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan.
  • Tabata M; Center for Clinical Oncology, Okayama University Hospital, Okayama, Japan.
  • Maeda Y; Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Kiura K; Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan.
Transl Lung Cancer Res ; 12(10): 2098-2112, 2023 Oct 31.
Article in En | MEDLINE | ID: mdl-38025818
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Transl Lung Cancer Res Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Transl Lung Cancer Res Year: 2023 Document type: Article Affiliation country: Country of publication: